[Jang R01AG058560 transfer] Role of BubR1 as a juvenile protective factor in hippocampal aging
【Jang R01AG058560转】BubR1作为幼年保护因子在海马衰老中的作用
基本信息
- 批准号:10469911
- 负责人:
- 金额:$ 34.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAdultAffectAgeAge-associated memory impairmentAgingAnxietyBUB1 geneBehaviorBehavioralBirthBrainCellsChildhoodClinicalCognitive agingCognitive deficitsDataDevelopmentDiseaseElectron MicroscopyElectrophysiology (science)ElementsEmbryoEtiologyExhibitsFunctional disorderGenerationsGeneticGoalsGrowthHippocampus (Brain)HumanImpaired cognitionImpairmentInterventionKnowledgeLifeMediatingMemoryMental DepressionMental RetardationMicrocephalyMitoticMitotic CheckpointMolecularMolecular TargetMusMutant Strains MiceMutationNeuronal PlasticityNeuronsPathologyPathway interactionsPatternPhosphotransferasesPlayPrevalenceProcessPublic HealthPublishingRegenerative MedicineRegulationRoleSynaptic plasticityTestingTherapeutic InterventionWNT Signaling PathwayWorkage relatedage related cognitive disorderage related neurodegenerationagedaging brainaging hippocampusbasebrain sizecognitive disabilitycognitive functionconfocal imagingdesignimprovedinhibitorinsightknock-downmouse geneticsnerve stem cellneurogenesisnew therapeutic targetnoveloverexpressionpostnatalpostnatal developmentpreventprotective factorssmall hairpin RNAtherapeutically effective
项目摘要
PROJECT SUMMARY
Aging is the most significant negative regulator of hippocampal neurogenesis, contributing to impairments in
synaptic plasticity and cognitive function. The main goal of this application is to identify juvenile protective
factors (JPFs) that are capable of maintaining neurogenesis and cognitive function in aged mice so that
effective therapeutic strategies for age-related cognitive disorders can be realized. Towards identifying novel
JPFs, we have recently provided first evidence that the mitotic checkpoint kinase BubR1 is required for
maintaining proper early brain development and hippocampal function later in life. Specifically, BubR1 level is
particularly high during early development and then declines to an adult level, followed by further decline
during the natural aging process. Given that neurogenesis is robust in childhood, but undergoes a progressive
decline with aging, such expression pattern of BubR1 correlates with age-dependent declines in neurogenesis.
However, whether sustained BubR1 levels have a protective role in the aged brain, and thus suggest a novel
JPF that maintains proper neurogenesis and related hippocampal function in aged mice, remains unknown.
Therefore, the main objective of this application is to resolve whether sustained high level of BubR1 in aged
brain prevents age-related hippocampal dysfunction. To support this idea, our preliminary data demonstrate
that BubR1 insufficiency accelerates age-dependent impairments in hippocampal neurogenesis. Importantly,
while a high level of BubR1 itself does not have any detrimental effects in young mice, it promotes
neurogenesis in aged mice. Based on these findings, our central hypothesis is that reduced BubR1 levels with
age contribute to age-dependent declines in hippocampal function, and that sustained high levels of BubR1
promote neurogenesis and improve synaptic plasticity and cognitive function in aged mice. Utilizing multiple
approaches including mouse genetics, confocal imaging, electrophysiology, and behavior analysis, Aim 1 will
determine a key downstream molecular pathway of BubR1 in regulating neurogenesis. Given the well-
established role of Wnt signaling in neurogenesis and aging, we will explore the involvement of the Wnt
signaling pathway in neurogenesis in both BubR1 insufficient and aged mice. Subsequently, Aim 2 will test
whether a sustained high level of BubR1 can restore hippocampal neurogenesis in aged mice. Lastly, Aim 3
will determine if a sustained high level of BubR1 improves synaptic plasticity and cognitive function in aged
mice in a neurogenesis-dependent manner. In summary, our findings will not only reveal the etiology of age-
related cognitive disorders, but also provide a framework by which therapeutic interventions may target
neurogenic declines during normal brain aging. Considering the prevalence of age-associated cognitive
deficits, determining the mechanistic elements improving hippocampal function will hold significant implications
for the fields of cognitive aging, neurogenesis, neural plasticity, regenerative medicine, and public health.
项目概要
衰老是海马神经发生最重要的负调节因子,导致海马神经发生损伤
突触可塑性和认知功能。该应用程序的主要目标是识别青少年保护
能够维持老年小鼠神经发生和认知功能的因子(JPF)
可以实现与年龄相关的认知障碍的有效治疗策略。识别小说
JPFs,我们最近提供了第一个证据,证明有丝分裂检查点激酶 BubR1 是
维持适当的早期大脑发育和晚年海马功能。具体来说,BubR1水平为
在早期发育期间特别高,然后下降到成年水平,然后进一步下降
在自然老化过程中。鉴于神经发生在儿童时期是强大的,但经历了一个渐进的过程
随着年龄的增长而下降,BubR1 的这种表达模式与神经发生的年龄依赖性下降相关。
然而,持续的 BubR1 水平是否对衰老的大脑具有保护作用,从而提出了一种新的方法
JPF 在老年小鼠中维持正常的神经发生和相关的海马功能仍然未知。
因此,本申请的主要目的是解决老年人体内BubR1是否持续高水平。
大脑可预防与年龄相关的海马功能障碍。为了支持这个想法,我们的初步数据表明
BubR1 不足会加速海马神经发生的年龄依赖性损伤。重要的是,
虽然高水平的 BubR1 本身不会对幼鼠产生任何有害影响,但它会促进
老年小鼠的神经发生。基于这些发现,我们的中心假设是,降低 BubR1 水平
年龄导致海马功能的年龄依赖性下降,并维持高水平的 BubR1
促进神经发生并改善老年小鼠的突触可塑性和认知功能。利用多个
目标 1 将采用包括小鼠遗传学、共焦成像、电生理学和行为分析在内的方法
确定 BubR1 在调节神经发生中的关键下游分子途径。鉴于良好
Wnt 信号在神经发生和衰老中的作用已经确定,我们将探讨 Wnt 的参与
BubR1 不足和老年小鼠神经发生中的信号通路。随后,Aim 2将测试
持续高水平的 BubR1 是否可以恢复老年小鼠的海马神经发生。最后,目标3
将确定持续高水平的 BubR1 是否可以改善老年人的突触可塑性和认知功能
小鼠以神经发生依赖的方式。总之,我们的研究结果不仅揭示了年龄的病因
相关的认知障碍,而且还提供了一个框架,通过该框架,治疗干预措施可以针对
正常大脑衰老过程中神经源性衰退。考虑到与年龄相关的认知能力的普遍存在
缺陷,确定改善海马功能的机制因素将具有重大意义
用于认知衰老、神经发生、神经可塑性、再生医学和公共卫生领域。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Editorial: Adult neurogenesis as a regenerative strategy for brain repair.
- DOI:10.3389/fnmol.2022.1041009
- 发表时间:2022
- 期刊:
- 影响因子:4.8
- 作者:Berg, Daniel A.;Cho, Kyung-Ok;Jang, Mi-Hyeon
- 通讯作者:Jang, Mi-Hyeon
The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive function.
- DOI:10.3389/fnmol.2023.1295991
- 发表时间:2023
- 期刊:
- 影响因子:4.8
- 作者:Rashid, Mohammad Abdur;Tang, Jason J.;Yoo, Ki-Hyun;Corujo-Ramirez, Ana;Oliveros, Alfredo;Kim, Sang Hoon;Ullah, Faheem;Altawell, Raad;Hawse, John R.;Cole, Peter D.;Jang, Mi-Hyeon
- 通讯作者:Jang, Mi-Hyeon
New Roles for Old Glue: Astrocyte Function in Synaptic Plasticity and Neurological Disorders.
- DOI:10.5213/inj.1836214.107
- 发表时间:2018-10
- 期刊:
- 影响因子:2.3
- 作者:Hussaini SMQ;Jang MH
- 通讯作者:Jang MH
Early stem cell aging in the mature brain.
- DOI:10.1016/j.stem.2021.03.018
- 发表时间:2021-05-06
- 期刊:
- 影响因子:23.9
- 作者:Ibrayeva A;Bay M;Pu E;Jörg DJ;Peng L;Jun H;Zhang N;Aaron D;Lin C;Resler G;Hidalgo A;Jang MH;Simons BD;Bonaguidi MA
- 通讯作者:Bonaguidi MA
Nicotinamide Mononucleotide Prevents Cisplatin-Induced Cognitive Impairments.
- DOI:10.1158/0008-5472.can-20-3290
- 发表时间:2021-07-01
- 期刊:
- 影响因子:11.2
- 作者:Yoo KH;Tang JJ;Rashid MA;Cho CH;Corujo-Ramirez A;Choi J;Bae MG;Brogren D;Hawse JR;Hou X;Weroha SJ;Oliveros A;Kirkeby LA;Baur JA;Jang MH
- 通讯作者:Jang MH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mi-Hyeon Jang其他文献
Mi-Hyeon Jang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mi-Hyeon Jang', 18)}}的其他基金
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10117840 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10688638 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10378837 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10759020 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10470574 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10459278 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10206070 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
9814276 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
Role of BubR1 as a juvenile protective factor in hippocampal aging
BubR1作为幼年保护因子在海马衰老中的作用
- 批准号:
10092880 - 财政年份:2018
- 资助金额:
$ 34.54万 - 项目类别:
Role of BubR1 as a juvenile protective factor in hippocampal aging
BubR1作为幼年保护因子在海马衰老中的作用
- 批准号:
9898040 - 财政年份:2018
- 资助金额:
$ 34.54万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
成人与儿童结核病发展的综合研究:细菌菌株和周围微生物组的影响
- 批准号:81961138012
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:国际(地区)合作与交流项目
统计学习影响成人汉语二语学习的认知神经机制
- 批准号:31900778
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Parent-adolescent informant discrepancies: Predicting suicide risk and treatment outcomes
父母与青少年信息差异:预测自杀风险和治疗结果
- 批准号:
10751263 - 财政年份:2024
- 资助金额:
$ 34.54万 - 项目类别:
Maternal immune activation remodeling of offspring glycosaminoglycan sulfation patterns during neurodevelopment
神经发育过程中后代糖胺聚糖硫酸化模式的母体免疫激活重塑
- 批准号:
10508305 - 财政年份:2023
- 资助金额:
$ 34.54万 - 项目类别:
Is gestational sleep apnea a previously unrecognized cause of maternal immune activation that predisposes male offspring to disease-relevant neural dysfunction?
妊娠期睡眠呼吸暂停是否是一种以前未被认识到的母体免疫激活的原因,导致男性后代容易出现与疾病相关的神经功能障碍?
- 批准号:
10680972 - 财政年份:2023
- 资助金额:
$ 34.54万 - 项目类别:
Imaging transcriptomics across developmental stages of early psychotic illness
早期精神病发展阶段的转录组学成像
- 批准号:
10664783 - 财政年份:2023
- 资助金额:
$ 34.54万 - 项目类别:
Expanding minority youth access to evidence-based care: A pilot effectiveness trial of a digital mental health intervention
扩大少数族裔青年获得循证护理的机会:数字心理健康干预措施的试点有效性试验
- 批准号:
10647287 - 财政年份:2023
- 资助金额:
$ 34.54万 - 项目类别: